Role of Vitamin D in Osteoarthritis: Molecular, Cellular, and Clinical Perspectives

TL;DR

This paper explores the complex role of vitamin D in osteoarthritis, highlighting conflicting findings from cellular and clinical studies.

Contribution

The paper synthesizes molecular, cellular, and clinical evidence to highlight the need for further research on vitamin D's role in osteoarthritis.

Findings

Cellular studies suggest vitamin D may negatively affect osteoarthritic joints.

Clinical research shows high vitamin D deficiency in osteoarthritis patients.

Trials on vitamin D supplementation have produced conflicting results on pain and joint function.

Abstract

Osteoarthritis is a debilitating and degenerative disease which affects millions of people worldwide. The causes and mechanisms of osteoarthritis remain to be fully understood. Vitamin D has been hypothesised to play essential roles in a number of diseases including osteoarthritis. Many cell types within osteoarthritic joints appear to experience negative effects often at increased sensitivity to vitamin D. These findings contrast clinical research which has identified vitamin D deficiency to have a worryingly high prevalence among osteoarthritis patients. Randomised-controlled trial is considered to be the most rigorous way of determining the effects of vitamin D supplementation on the development of osteoarthritis. Studies into the effects of low vitamin D levels on pain and joint function have to date yielded controversial results. Due to the apparent conflicting effects of vitamin D in knee osteoarthritis, further research is required to fully elucidate its role in the development and progression of the disease as well as assess the efficacy and safety of vitamin D supplementation as a therapeutic strategy.

Figures